Cargando…

Bioinformatics exploration of potential common therapeutic targets for systemic and pulmonary arterial hypertension-induced myocardial hypertrophy: Common therapeutic target for left and right ventricular hypertrophy

Systemic and pulmonary arterial hypertension (PAH) can induce left and right ventricular hypertrophy, respectively, but common therapeutic targets for both left and right hypertrophy are limited. In this study, we attempt to explore potential common therapeutic targets and screen out potential targe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Lu, Li, Mingjue, Shen, Mengjia, Zhu, Yingqi, Chen, Kaitong, Huang, Xiaoxia, Zheng, Cankun, Wang, Qiancheng, Lin, Hairuo, Liao, Wangjun, Bin, Jianping, Ma, Siyuan, Liao, Yulin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281875/ https://www.ncbi.nlm.nih.gov/pubmed/37232575 http://dx.doi.org/10.3724/abbs.2023071

Ejemplares similares

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
por: Zheng, Cankun, et al.
Publicado: (2022)

Characterizing a long-term chronic heart failure model by transcriptomic alterations and monitoring of cardiac remodeling
por: Zhu, Yingqi, et al.
Publicado: (2021)

RNA interactions in right ventricular dysfunction induced type II cardiorenal syndrome
por: Chen, Kaitong, et al.
Publicado: (2021)

Antihypertrophic Memory After Regression of Exercise-Induced Physiological Myocardial Hypertrophy Is Mediated by the Long Noncoding RNA Mhrt779
por: Lin, Hairuo, et al.
Publicado: (2021)

Excessive fibroblast growth factor 23 promotes renal fibrosis in mice with type 2 cardiorenal syndrome
por: Hao, Huixin, et al.
Publicado: (2021)

A Bibliometric and Visualized Analysis of Cardiac Regeneration Over a 20-Year Period
por: Ma, Siyuan, et al.
Publicado: (2021)

Bibliometric Study of Sodium Glucose Cotransporter 2 Inhibitors in Cardiovascular Research
por: Chen, Lu, et al.
Publicado: (2020)

Growth differentiation factor 11 attenuates cardiac ischemia reperfusion injury via enhancing mitochondrial biogenesis and telomerase activity
por: Chen, Lin, et al.
Publicado: (2021)

Calpains as Potential Therapeutic Targets for Myocardial Hypertrophy
por: Aluja, David, et al.
Publicado: (2022)

Transcription Factors in Heart: Promising Therapeutic Targets in Cardiac Hypertrophy
por: Kohli, Shrey, et al.
Publicado: (2011)

A Modified Surgical Ventricular Reconstruction in Post-infarction Mice Persistently Alleviates Heart Failure and Improves Cardiac Regeneration
por: Ma, Siyuan, et al.
Publicado: (2021)

Na(+)/H(+) Exchanger 1, a Potential Therapeutic Drug Target for Cardiac Hypertrophy and Heart Failure
por: Xia, Huiting, et al.
Publicado: (2022)

Mitochondria-associated endoplasmic reticulum membranes and cardiac hypertrophy: Molecular mechanisms and therapeutic targets
por: Luan, Yi, et al.
Publicado: (2022)

Distal-Less Homeobox 5 Is a Therapeutic Target for Attenuating Hypertrophy and Apoptosis of Mesenchymal Progenitor Cells
por: Twomey-Kozak, John, et al.
Publicado: (2020)

Olmesartan attenuates pressure-overload- or post-infarction-induced cardiac remodeling in mice
por: Wang, Qiancheng, et al.
Publicado: (2017)

Mapping drug-target interactions and synergy in multi-molecular therapeutics for pressure-overload cardiac hypertrophy
por: Rai, Aparna, et al.
Publicado: (2021)

Therapeutic potential and recent advances on targeting mitochondrial dynamics in cardiac hypertrophy: A concise review
por: Aung, Lynn Htet Htet, et al.
Publicado: (2021)

CCL17 acts as a novel therapeutic target in pathological cardiac hypertrophy and heart failure
por: Zhang, Yang, et al.
Publicado: (2022)

Heart-targeting exosomes from human cardiosphere-derived cells improve the therapeutic effect on cardiac hypertrophy
por: Mao, Liang, et al.
Publicado: (2022)

Common therapeutic target for both cancer and obesity
por: Chang, Yie-Hwa
Publicado: (2017)

Left Ventricular Hypertrophy: Etiology-Based Therapeutic Options
por: Sayin, Begum Yetis, et al.
Publicado: (2022)

Retrograde Ejaculation—a Commonly Unspoken Aspect of Prostatectomy for Benign Prostatic Hypertrophy
por: Koren, Gideon, et al.
Publicado: (2020)

Adipose Tissue Hyperplasia and Hypertrophy in Common and Syndromic Obesity—The Case of BBS Obesity
por: Horwitz, Avital, et al.
Publicado: (2023)

Non-Coding RNAs in the Therapeutic Landscape of Pathological Cardiac Hypertrophy
por: Silva, Joana, et al.
Publicado: (2022)

Mechanism of histone deacetylases in cardiac hypertrophy and its therapeutic inhibitors
por: Han, Yu, et al.
Publicado: (2022)

Influences of Adenoid Hypertrophy on Children’s Maxillofacial Development
por: Lan, Yulin, et al.
Publicado: (2023)

Analysis of Therapeutic Targets of A Novel Peptide Athycaltide-1 in the Treatment of Isoproterenol-Induced Pathological Myocardial Hypertrophy
por: Zheng, Xi, et al.
Publicado: (2022)

Osteoarthritis: pathogenic signaling pathways and therapeutic targets
por: Yao, Qing, et al.
Publicado: (2023)

Exploring Key Genes and Pathways of Cardiac Hypertrophy Based on Bioinformatics
por: Zhang, Zhenzhen, et al.
Publicado: (2022)

Hypertrophy
Publicado: (1860)

Assessment of Common and Emerging Bioinformatics Pipelines for Targeted Metagenomics
por: Siegwald, Léa, et al.
Publicado: (2017)

Disclosing common biological signatures and predicting new therapeutic targets in schizophrenia and obsessive–compulsive disorder by integrated bioinformatics analysis
por: Ghanbarzehi, Abdolhakim, et al.
Publicado: (2023)

Repression of Cardiac Hypertrophy by KLF15: Underlying Mechanisms and Therapeutic Implications
por: Leenders, Joost J., et al.
Publicado: (2012)

Potentially Common Therapeutic Targets for Multiple Sclerosis and Ischemic Stroke
por: Paternò, Roberto, et al.
Publicado: (2018)

Tau: A Common Denominator and Therapeutic Target for Neurodegenerative Disorders
por: Maxan, Alexander, et al.
Publicado: (2018)

CDC20 regulates cardiac hypertrophy via targeting LC3-dependent autophagy
por: Xie, Yun-Peng, et al.
Publicado: (2018)

Cytosolic CARP Promotes Angiotensin II- or Pressure Overload-Induced Cardiomyocyte Hypertrophy through Calcineurin Accumulation
por: Chen, Ci, et al.
Publicado: (2014)

miR-217 Promotes Cardiac Hypertrophy and Dysfunction by Targeting PTEN
por: Nie, Xiang, et al.
Publicado: (2018)

Ascending aorta dilatation common feature which correlate with left ventricular hypertrophy in fabry disease
por: Bensalah, Mourad, et al.
Publicado: (2011)

Teres Minor Hypertrophy is a Common and Negative Predictor of Outcomes after Rotator Cuff Repair
por: Tokish, John M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_849sg1gn9b8soe7is5ul2n0vrn